Stockholders’ Equity (Deficit) | Note 9 – Stockholders’ Equity (Deficit) Series C Preferred Stock On February 24, 2021, the Company sold 179,850 8 163,500 25 1,208,971 113,850 103,500 165,142 11,748 26,159,396 On December 16, 2019, the Company sold 140,000 130,000 1,500,000 30 165,218 190,131 8,750 140,000 131,250 140,000 21,744,479 On March 3, 2020, the Company sold 55,800 50,000 88,868 55,800 10,598,864 On April 14, 2020, the Company sold 55,800 50,000 82,028 55,800 15,292,885 The tables below provide the preferred stock activity for the year ended December 31, 2021 and 2020, and also a reconciliation of the beginning and ending balances for the derivative liabilities measured using Level 3 fair value inputs for the year ended December 31, 2021 and 2020 Preferred Discount Preferred Derivative Balance , January 1, 2020 $ 140,000 $ 131,250 $ 8,750 $ 190,131 Issuance of Series C Preferred shares 111,600 111,600 — 170,896 Conversion of Series C Preferred shares and accrued dividend (265,115 ) (175,820 ) (89,295 ) (353,005 ) Accretion of discount (67,030 ) 67,030 — Accretion of conversion feature on Series C preferred stock 13,515 — 13,515 23,290 Change in fair value of derivatives — — — (31,312 ) Balance, December 31, 2020 — — — — Issuance of Series C Preferred shares 293,700 293,700 — 1,374,113 Conversion of Series C Preferred shares and accrued dividend (305,448 ) (210,121 ) (95,327 ) (338,228 ) Accretion of discount — (83,579 ) 83,579 — Accretion of dividend on Series C preferred stock 11,748 — 11,748 13,948 Change in fair value of derivatives — — — (1,049,833 ) Balance December 31, 2021 $ — $ — $ — $ — The following assumptions were used in the Binomial Option Pricing Model in calculating the embedded conversion features and current liabilities for the years ended December 31, 2021 and 2020: 2021 2020 Risk-free interest rates 0.12 0.28 0.11 0.23 Expected life (years) 1.4 2.0 1.5 2.0 Expected dividends 0 0 Expected volatility 184 196 172 262 Common Stock 2021 Transactions During the year ended December 31, 2021, $ 100,000 6,256 5,026,413 705,635 During the year ended December 31, 2021, 6,498,837 162,505 7,635,992 172,283 594,532 1,731,687 3,586 13,364 During the year ended December 31, 2021, 527,085 8,000 1,137,826 16,000 495,116 1,105,857 6,000 14,000 At December 31, 2021 and 2020, shares to be issued for debt conversions were 31,960 21,861 During the year ended December 31, 2021, 26,159,396 293,700 11,748 During the year ended December 31, 2021, we issued 30,000 1,915 2020 Transactions During the year ended December 31, 2020, $ 180,922 14,702 39,489,099 328,887 5,835 53,567 180,995 During the year ended December 31, 2020, 10,935,040 117,887 12,219,836 177,323 283,182 6,914 During the year ended December 31, 2020, 905,658 8,003 9,583 5,601 During the year ended December 31, 2020, we reversed the over accrual of 3,884 13,983 During the year ended December 31, 2020, we issued 4,000,000 51,200 During the year ended December 31, 2020, 47,636,228 251,600 Common stock warrant activity: The Company has determined that certain of its warrants are subject to derivative accounting. The table below provides a reconciliation of the beginning and ending balances for the warrant liabilities measured using fair significant unobservable inputs (Level 3) for the years ended December 31, 2020 and 2019: Year ended December 31, 2021 2020 Balance at beginning of year $ 476 $ 967 Additions to derivative instruments — — Loss (gain) on change in fair value of derivative liability (38 ) (491 ) Balance at end of year $ 438 $ 476 The following assumptions were used in the Binomial Option Pricing Model in calculating the embedded conversion features and current liabilities for the years ended December 31, 2021 and 2020: December 31, 2021 December 31, 2020 Annual dividend yield 0 % 0 % Expected life (years) 1.0 6.13 0.42 7.38 Risk-free interest rate 0.09 1.26 % 0.10 1.83 % Expected volatility 189 243 % 186 240 % The following table summarizes stock warrant activity for the years ended December 31, 2021 and 2020: Number of Weighted- Weighted- Outstanding at December 31, 2019 211,826 $ 10.08 Granted — $ — Expired (78,031 ) $ 18.72 Outstanding at December 31, 2020 133,795 $ 5.04 4.4 Granted — $ — Expired (31,295 ) $ 6.23 Outstanding at December 31, 2021 102,500 $ 4.68 4.4 Exercisable at December 31, 2021 102,500 $ 4.68 4.4 Common stock option activity: The Company maintains an Equity Incentive Plan pursuant to which 124,000 shares of common stock are reserved for issuance thereunder. This Plan was established to award certain founding members, who were instrumental in the development of the Company, as well as key employees, directors and consultants, and to promote the success of the Company’s business. The terms allow for each option to vest immediately, with a term no greater than 10 years from the date of grant, at an exercise price equal to par value at date of the grant. As of December 31, 2021, 10,000 awards are outstanding pursuant to the plan. There remain 114,000 shares available for future grants. During the years ended December 31, 2021 and 2020, the Company recorded total option expense of $0 and $86,606, respectively. There was no unamortized stock option expense at December 31, 2021. The aggregate intrinsic value of stock options outstanding at December 31, 2021 is $0. The following table summarizes stock option activity for the years ended December 31, 2021 and 2020: Number of Weighted- Weighted- Outstanding at December 31, 2019 172,480 $ 5.29 Granted — $ — Expired — $ — Outstanding at December 31, 2020 172,480 $ 5.29 4.5 Granted — $ — Expired (50,000 ) $ 6.00 Outstanding at December 31, 2021 122,480 $ 5.00 5.1 Exercisable at December 31, 2021 122,480 $ 5.00 5.1 |